Literature DB >> 11080186

Tau protein is hyperphosphorylated in a site-specific manner in apoptotic neuronal PC12 cells.

J Zhang1, G V Johnson.   

Abstract

Alterations in the status of microtubules contribute to the cytoskeletal rearrangements that occur during apoptosis. The microtubule-associated protein tau regulates microtubule dynamics and thus is likely to play an important role in the cytoskeletal changes that occur in apoptotic cells. Previously, we demonstrated that the phosphorylation of tau at the Tau-1 epitope was increased during neuronal PC12 cell apoptosis, and further that the microtubule binding of tau from apoptotic cells was significantly impaired because of altered phosphorylation. The fact that the microtubule-binding capacity of tau from apoptotic cells was reduced to approximately 30% of control values indicated that sites in addition to those within the Tau-1 epitope were hyperphosphorylated during apoptosis. In this study using a combination of immunological and biochemical approaches, numerous sites were found to be hyperphosphorylated on tau isolated from apoptotic cells. Further, during apoptosis, the activities of cell division control protein kinase (cdc2) and cyclin-dependent kinase 5 (cdk5) were selectively and significantly increased. The association of these two protein kinases with tau was also increased during apoptosis. These findings are intriguing because many of the sites found to be hyperphosphorylated on tau during apoptosis are also hyperphosphorylated on tau from Alzheimer's disease brain. Likewise, there are data indicating that in Alzheimer's disease the activities of cdc2 and cdk5 are also increased.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11080186     DOI: 10.1046/j.1471-4159.2000.0752346.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Pre-aggregated Aβ1-42 peptide increases tau aggregation and hyperphosphorylation after short-term application.

Authors:  Sabine Ott; Andreas Wolfram Henkel; Maria Kerstin Henkel; Zoran B Redzic; Johannes Kornhuber; Jens Wiltfang
Journal:  Mol Cell Biochem       Date:  2010-11-27       Impact factor: 3.396

2.  A nestin scaffold links Cdk5/p35 signaling to oxidant-induced cell death.

Authors:  Cecilia M Sahlgren; Hanna-Mari Pallari; Tao He; Ying-Hao Chou; Robert D Goldman; John E Eriksson
Journal:  EMBO J       Date:  2006-10-12       Impact factor: 11.598

3.  Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival.

Authors:  Ya-Li Zheng; Bing-Sheng Li; Jyotshna Kanungo; Sashi Kesavapany; Niranjana Amin; Philip Grant; Harish C Pant
Journal:  Mol Biol Cell       Date:  2006-11-15       Impact factor: 4.138

4.  The Notch signaling inhibitor DAPT down-regulates cdk5 activity and modulates the distribution of neuronal cytoskeletal proteins.

Authors:  Jyotshnabala Kanungo; Ya-Li Zheng; Niranjana D Amin; Harish C Pant
Journal:  J Neurochem       Date:  2008-07-04       Impact factor: 5.372

5.  GT1b-induced neurotoxicity is mediated by the Akt/GSK-3/tau signaling pathway but not caspase-3 in mesencephalic dopaminergic neurons.

Authors:  Eun S Chung; Eugene Bok; Sunghyang Sohn; Young D Lee; Hyung H Baik; Byung K Jin
Journal:  BMC Neurosci       Date:  2010-06-12       Impact factor: 3.288

Review 6.  In vitro cultured neurons for molecular studies correlating apoptosis with events related to Alzheimer disease.

Authors:  Nadia Canu; Pietro Calissano
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

7.  PSEA: Kinase-specific prediction and analysis of human phosphorylation substrates.

Authors:  Sheng-Bao Suo; Jian-Ding Qiu; Shao-Ping Shi; Xiang Chen; Ru-Ping Liang
Journal:  Sci Rep       Date:  2014-03-31       Impact factor: 4.379

8.  Activation of cyclin-dependent kinase 5 is a consequence of cell death.

Authors:  Yixia Ye; Antonella Tinari; Walter Malorni; Richard A Lockshin; Zahra Zakeri
Journal:  J Biomed Biotechnol       Date:  2009-10-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.